First Time Loading...

Bionime Corp
TWSE:4737

Watchlist Manager
Bionime Corp Logo
Bionime Corp
TWSE:4737
Watchlist
Price: 69.9 TWD -1.13% Market Closed
Updated: May 13, 2024

Wall Street
Price Targets

Price Targets Summary
Bionime Corp

Wall Street analysts forecast Bionime Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Bionime Corp is 121 TWD .

Lowest
Price Target
Not Available
Average
Price Target
121 TWD
73% Upside
Highest
Price Target
Not Available
Bionime Corp Competitors:
Price Targets
6960
Fukuda Denshi Co Ltd
31% Downside
OPTOMED
Optomed Oyj
10% Upside
78W
Modulight Oyj
88% Upside
PODD
Insulet Corp
44% Upside
SRTS
Sensus Healthcare Inc
29% Upside
300326
Shanghai Kinetic Medical Co Ltd
4% Downside
MYO
Myomo Inc
46% Upside
CLPT
Clearpoint Neuro Inc
74% Upside

Revenue
Forecast

Revenue Estimate
Bionime Corp

For the last 8 years the compound annual growth rate for Bionime Corp's revenue is 1%. The projected CAGR for the next 1 year is 22%.

1%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bionime Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Bionime Corp

For the last 8 years the compound annual growth rate for Bionime Corp's net income is -29%. The projected CAGR for the next 1 year is 1 042%.

-29%
Past Growth
1 042%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Bionime Corp's stock price target?
Price Target
121 TWD

According to Wall Street analysts, the average 1-year price target for Bionime Corp is 121 TWD .

What is Bionime Corp's Revenue forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Bionime Corp's revenue is 1%. The projected CAGR for the next 1 year is 22%.

What is Bionime Corp's Net Income forecast?
Projected CAGR
1 042%

For the last 8 years the compound annual growth rate for Bionime Corp's net income is -29%. The projected CAGR for the next 1 year is 1 042%.